The report on the Global RNA Interference Market gives an estimation of the development of the market based on historical studies and also provides forecasts on the basis of comprehensive research. The report gives a complete market analysis for the forecasted period from 2020 to 2026. The market is divided into various segments with an in-depth outlook of the competitors and a listing of the profiled key players. The market size in terms of revenue (USD MN) is calculated and provided for the study period along with the dynamics of the market such as the drivers and the restraints.
RNAi (Ribonucleic Acid Interference) is an RNA-dependent gene silencing process that occurs in live cells to keep a check on the active genes. The major classes of RNAi are micro RNA and small interfering RNA. It is a valuable research tool to selectively induce suppression of genes of interest. RNAi is said to replace the existing recombinant technology in the field of drug discovery and therapeutics.
RNA Interference (RNAi) market is segmented by products, applications, delivery modes, and end users. RNA Interference (RNAi) market by products is segmented into design, monitoring/optimizing, and libraries. Based on the libraries, the market is divided into humans, mice, and rats. On the basis of applications, the market is segmented into research and development, therapeutics, drug discovery and development, and agriculture. Based on delivery mode, this market is segmented into vector based, transfection reagents, and electroporation. On the basis of end users, the market is divided into pharmaceutical companies, agriculture based industries, and biotechnology companies. Based on geographies, the market is divided into North America, Europe, Asia, and Rest of World (RoW).
The major factors driving growth of this market are increase in RNA therapeutic development and requirement of lower therapeutic dosages. Inefficiency in RNA drug delivery system is the major restraining factor to this market. Agriculture is an emerging field to use RNAi technology for crop improvement.
Some of the key players in this market are:
- Qiagen N. V.
- Invitrogen Corporation
- Ambion, Inc.
- Tekmira Pharmaceuticals Corporation
- Merck & Co., Inc.
SEGMENTATIONS IN THE REPORT:
By Products:
- Design
- Monitoring/optimizing
- Libraries
By Applications:
- Research and Development
- Therapeutics
- Drug discovery and Development
- Agriculture
By Delivery Modes:
- Vector Based
- Transfection Reagents
- Electroporation
By End Users:
- Pharmaceutical Companies
- Agriculture Based Industries
- Biotechnology Companies
By Geography:
- North America (NA) – US, Canada & Rest of North America
- Europe (EU) – UK, Germany, France & Rest of Europe
- Asia Pacific (APAC) – China, Japan, India & Rest of APAC
- Latin America (LA) – Brazil & Rest of Latin America
- Middle East & Africa (MEA) – Middle East and Africa
The Global RNA Interference Market has been exhibited in detail in the following chapters -
Chapter 1 RNA Interference Market Preface
Chapter 2 Executive Summary
Chapter 3 RNA Interference Industry Analysis
Chapter 4 RNA Interference Market Value Chain Analysis
Chapter 5 RNA Interference Market Analysis By Products
Chapter 6 RNA Interference Market Analysis By Applications
Chapter 7 RNA Interference Market Analysis By Delivery Modes
Chapter 8 RNA Interference Market Analysis By End Users
Chapter 9 RNA Interference Market Analysis By Geography
Chapter 10 Competitive Landscape Of RNA Interference Companies
Chapter 11 Company Profiles Of RNA Interference Industry